NUC-3373 is a 5-FU prodrug based on ProTide technology that is able to generate much higher concentrations of FUDR-MP in patients' cells. It is reported to be effective against COVID-19. NUC-3373 also has a more convenient administration schedule and does not produce toxic levels of metabolites such as FBAL which results in an improved safety profile. NUC-3373 is a more potent and targeted inhibitor of TS.

纯度：≥98%

CAS：1332837-31-6